Japanese encephalitis - the prospects for new treatments. (Q54227730)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29697099%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

title

Japanese encephalitis - the prospects for new treatments (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29697099%20AND%20SRC:MED&resulttype=core&format=json

Japanese encephalitis virus

24 March 2020

main subject

0 references

Japanese encephalitis

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29697099%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Tom Solomon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29697099%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

author name string

Tom Solomon

series ordinal

2

1 reference

26 May 2018

http://europepmc.org/abstract/MED/29697099

language of work or name

English

0 references

publication date

1 April 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29697099%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

published in

Nature Reviews Neurology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29697099%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29697099%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29697099%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

page(s)

298-313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29697099%20AND%20SRC:MED&resulttype=core&format=json

Estimated global incidence of Japanese encephalitis: a systematic review

24 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Measuring the burden of neglected tropical diseases: the global burden of disease framework

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Molecular biology of flaviviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Complete nucleotide sequence of the Japanese encephalitis virus genome RNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Ecologic studies of Japanese encephalitis virus in Japan. IX. Epidemiologic correlations and conclusions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Cyclic outbreaks of Japanese encephalitis among pigs and humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Rethinking Japanese Encephalitis Virus Transmission: A Framework for Implicating Host and Vector Species

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Autochthonous Japanese Encephalitis with Yellow Fever Coinfection in Africa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Vector-free transmission and persistence of Japanese encephalitis virus in pigs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

31 March 2020

Japanese Encephalitis

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Acute phase of Japanese B encephalitis; two hundred and one cases in American soldiers, Korea, 1950

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis in travelers from non-endemic countries, 1973-2008

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Viral etiology of acute childhood encephalitis in Beijing diagnosed by analysis of single samples

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

First indigenous transmission of Japanese Encephalitis in urban areas of National Capital Territory of Delhi, India

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Study of Japanese encephalitis virus in Chiangmia Valley, Thailand. VI. Summary and conclusions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Serological studies of encephalitis in Japan. II. Inapparent infections by Japanese B encephalitis virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Study of Japanese encephalitis virus in Chiangmai Valley, Thailand. 3. Human seroepidemiology and inapparent infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Movement disorders in Japanese encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Poliomyelitis-like illness due to Japanese encephalitis virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Clinical features in children hospitalized during the 2005 epidemic of Japanese encephalitis in Uttar Pradesh, India

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Association of Japanese encephalitis virus infection with Guillain-Barré syndrome in endemic areas of south India.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Guillain-Barré syndrome associated with Japanese encephalitis virus infection in China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Acute flaccid paralysis and West Nile virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Neurological complications of dengue virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Guillain-Barré syndrome: An unusual presentation of West Nile virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Acute transverse myelitis following Japanese encephalitis viral infection: an uncommon complication of a common disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis can trigger anti-N-methyl-D-aspartate receptor encephalitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Transplacental Infection with Japanese Encephalitis Virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

An appraisal of clinicopathological parameters in Japanese encephalitis and changing epidemiological trends in upper Assam, India

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Clinical and prognostic features among children with acute encephalitis syndrome in Nepal; a retrospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis associated acute encephalitis syndrome cases in West Bengal, India: A sero-molecular evaluation in relation to clinico-pathological spectrum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Detection and isolation of Japanese encephalitis virus from blood clots collected during the acute phase of infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis virus RNA not detected in urine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Can we differentiate between herpes simplex encephalitis and Japanese encephalitis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

An evaluation of the usefulness of neuroimaging for the diagnosis of Japanese encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Protection against Japanese encephalitis by inactivated vaccines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis--an important cause of acute childhood encephalopathy in Lucknow, India

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Effect of High-Dose Dexamethasone on the Outcome of Acute Encephalitis Due to Japanese Encephalitis Virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Clinical and immunological risk factors for severe disease in Japanese encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

A comparison of clinical and radiological findings in adults and children with Japanese encephalitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Management parameters affecting the outcome of Japanese encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

A large outbreak of Japanese encephalitis predominantly among adults in northern region of West Bengal, India

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Outcome of children with Japanese encephalitis and predictors of outcome in southwestern China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Outcome and extent of disability following Japanese encephalitis in Indonesian children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis virus remains an important cause of encephalitis in Thailand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

The epidemiology, clinical features, and long-term prognosis of Japanese encephalitis in central sarawak, malaysia, 1997-2005.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Endemic Japanese encephalitis in the Kathmandu valley, Nepal.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese Encephalitis Disease Burden and Clinical Features of Japanese Encephalitis in Four Cities in the People's Republic of China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Laboratory diagnosis of Japanese encephalitis using monoclonal antibodies and correlation of findings with the outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Co-existence of cerebral cysticercosis with Japanese encephalitis: a prognostic modulator

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis in and around Pondicherry, South India: a clinical appraisal and prognostic indicators for the outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Clinico-laboratory profile and outcome of Japanese encephalitis in Nepali children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Laboratory-based Japanese encephalitis surveillance in Nepal and the implications for a national immunization strategy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Confirmation of Japanese encephalitis as an endemic human disease through sentinel surveillance in Indonesia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Epidemiology and burden of disease from Japanese encephalitis in Cambodia: results from two years of sentinel surveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Surveillance for Japanese Encephalitis in Vietnam, 1998–2007

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Hospital-Based Surveillance for Japanese Encephalitis at Four Sites in Bangladesh, 2003-2005

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

A comparison of clinical features of Japanese encephalitis virus infection in the adult and pediatric age group with Acute Encephalitis Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Viral aetiology of central nervous system infections in adults admitted to a tertiary referral hospital in southern Vietnam over 12 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Persistence of Japanese encephalitis virus in the human nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis virus latency in peripheral blood lymphocytes and recurrence of infection in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Persistence, latency and reactivation of Japanese encephalitis virus infection in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Persistent Infection with West Nile Virus Years after Initial Infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Persistence of Japanese encephalitis virus is associated with abnormal expression of the nonstructural protein NS1 in host cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Highly permissive infection of microglial cells by Japanese encephalitis virus: a possible role as a viral reservoir

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

A model to study neurotropism and persistency of Japanese encephalitis virus infection in human neuroblastoma cells and leukocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Origin and Evolution of Japanese Encephalitis Virus in Southeast Asia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Phylogeography of Japanese encephalitis virus: genotype is associated with climate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Comparison of genotypes I and III in Japanese encephalitis virus reveals distinct differences in their genetic and host diversity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Molecular characterization of the first Australian isolate of Japanese encephalitis virus, the FU strain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Short report: the first isolation of Japanese encephalitis virus from mosquitoes collected from mainland Australia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Ecology and geographical expansion of Japanese encephalitis virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Potential for the emergence of Japanese encephalitis virus in California

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Does the Japanese encephalitis virus (JEV) represent a threat for human health in Europe? Detection of JEV RNA sequences in birds collected in Italy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis virus RNA detected in Culex pipiens mosquitoes in Italy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Lot-to-lot consistency of live attenuated SA 14-14-2 Japanese encephalitis vaccine manufactured in a good manufacturing practice facility and non-inferiority with respect to an earlier product

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Isolation and genetic characteristics of human genotype 1 Japanese encephalitis virus, China, 2009.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Genotype v Japanese encephalitis virus is emerging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years, India, 2013 and updates on immunization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Assessment of neutralizing antibodies elicited by a vaccine (Nakayama) strain of Japanese encephalitis virus in Taiwan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Functional modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor molecule-dependent and -independent pathways.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis Virus wild strain infection suppresses dendritic cells maturation and function, and causes the expansion of regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Infection of mouse bone marrow-derived dendritic cells by live attenuated Japanese encephalitis virus induces cells maturation and triggers T cells activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis virus expands regulatory T cells by increasing the expression of PD-L1 on dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Human skin Langerhans cells are targets of dengue virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Incubation Periods of Mosquito-Borne Viral Infections: A Systematic Review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis virus antigen in the human brain and its topographic distribution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Understanding the molecular mechanism of blood-brain barrier damage in an experimental model of Japanese encephalitis: correlation with minocycline administration as a therapeutic agent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Neuropathogenesis of Japanese encephalitis in a primate model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Phenotypes of mononuclear cell infiltrates in human central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Japanese encephalitis: identification of inflammatory cells in cerebrospinal fluid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Immunohistochemical demonstration of viral antigens in Japanese encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Distinct dictation of Japanese encephalitis virus-induced neuroinflammation and lethality via triggering TLR3 and TLR4 signal pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Amelioration of Japanese encephalitis by blockage of 4-1BB signaling is coupled to divergent enhancement of type I/II IFN responses and Ly-6C(hi) monocyte differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

CCL2, but not its receptor, is essential to restrict immune privileged central nervous system-invasion of Japanese encephalitis virus via regulating accumulation of CD11b(+) Ly-6C(hi) monocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Proinflammatory cytokines and chemokines in humans with Japanese encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Etanercept reduces neuroinflammation and lethality in mouse model of Japanese encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Cytolytic effector pathways and IFN-γ help protect against Japanese encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

CD8 T cells protect adult naive mice from JEV-induced morbidity via lytic function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Human T cell responses to Japanese encephalitis virus in health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Mortality after fluid bolus in African children with severe infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Regulation of antibody responses via antibodies, complement, and Fc receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Role of oral Minocycline in acute encephalitis syndrome in India - a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Potential chemotherapeutic targets for Japanese encephalitis: current status of antiviral drug development and future challenges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Novel strategy for treatment of Japanese encephalitis using arctigenin, a plant lignan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Identification of three antiviral inhibitors against Japanese encephalitis virus from library of pharmacologically active compounds 1280

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Fenofibrate reduces mortality and precludes neurological deficits in survivors in murine model of Japanese encephalitis viral infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Use of pentoxifylline in treatment of children with dengue hemorrhagic fever.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Pentoxifylline inhibits replication of Japanese encephalitis virus: a comparative study with ribavirin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

The TLR4 antagonist Eritoran protects mice from lethal influenza infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Quantitative phosphoproteomic analysis identifies the critical role of JNK1 in neuroinflammation induced by Japanese encephalitis virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Disability after encephalitis: development and validation of a new outcome score.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Crystal Structure of the Japanese Encephalitis Virus Envelope Protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

Encephalitis caused by flaviviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2018.30

7 January 2021

inferred from DOI database lookup

Breakdown of blood-brain barrier by virus-induced cytokine during Japanese encephalitis virus infection

1 reference

12 December 2020

Clinical features & prognostic indicators of Japanese encephalitis in children in Lucknow (India).

1 reference

12 December 2020

Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies

1 reference

12 December 2020

A review of Japanese encephalitis cases in the Philippines (1972-1985).

1 reference

12 December 2020

Immunopathological study of spleen during Japanese encephalitis virus infection in mice

1 reference

12 December 2020

Isolation of Japanese encephalitis virus from clinical specimens using a continuous mosquito cell line

1 reference

12 December 2020

Comparative epidemiological features of Japanese encephalitis in the Republic of Korea, China (Taiwan) and Japan.

1 reference

12 December 2020

The effect of vaccination with a live attenuated strain of Japanese encephalitis virus on stillbirths in swine in Taiwan

1 reference

12 December 2020

JE virus encephalitis: 1988 epidemic at Gorakhpur.

1 reference

12 December 2020

The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes

1 reference

12 December 2020

Japanese encephalitis in north Queensland, Australia, 1998.

1 reference

12 December 2020

Production of lethal infection that resembles fatal human disease by intranasal inoculation of macaques with Japanese encephalitis virus

1 reference

12 December 2020

Clinical outcome and neurological sequelae in serologically confirmed cases of Japanese encephalitis patients in Assam, India

1 reference

12 December 2020

Acute undifferentiated fever caused by infection with Japanese encephalitis virus

1 reference

12 December 2020

THE PATHOLOGY OF JAPANESE ENCEPHALITIS. A REVIEW

1 reference

12 December 2020

Epidemiology of the arthropod-borne encephalitides

1 reference

12 December 2020

Immunologic studies of Japanese encephalitis virus in Japan. II. Antibody responses following inapparent human infection

1 reference

12 December 2020

Japanese encephalitis virus infects neural progenitor cells and decreases their proliferation

1 reference

12 December 2020

Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004.

1 reference

12 December 2020

Japanese encephalitis in mainland china

1 reference

12 December 2020

Retrospective screening of serum and cerebrospinal fluid samples from patients with acute meningo-encephalitis does not reveal past Japanese encephalitis virus infection, Emilia Romagna, Italy, 2011.

1 reference

12 December 2020

A possible case of acute disseminated encephalomyelitis after Japanese encephalitis

1 reference

12 December 2020

Clinical profile and outcome of Japanese encephalitis in children admitted with acute encephalitis syndrome.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEUROL.2018.30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29697099%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference